Search results
- title = The total number and mass of SARS-CoV-2 virions |url=https://www.medrxiv.org/content/10.1101/2020.11.16.20232009v2 |journal=MedRxiv: The Preprint...122 KB (12,477 words) - 16:05, 1 December 2024
- this varies significantly across region.<ref>{{Cite web|url=https://www.medrxiv.org/content/10.1101/2023.03.02.23286692v1|title=Colorectal Cancer Risk and...91 KB (9,706 words) - 05:18, 1 January 2025
- South African Cape Coloured population |date=2024-04-01 |url=https://www.medrxiv.org/content/10.1101/2024.03.31.24305130v2 |access-date=2024-12-16 |language=en...81 KB (8,379 words) - 14:31, 6 January 2025
- social distancing behavior during the COVID-19 pandemic|url=https://www.medrxiv.org/content/10.1101/2020.05.01.20087874v1.full.pdf|url-status=live|doi=10...64 KB (14,599 words) - 04:27, 30 December 2024
- ||style="background: orange;"|46.5%|| Community-based health insurance<ref>[https://www.medrxiv.org/content/medrxiv/early/2023/07/07/2023.07.05.23292262.full.pdf The Introduction...178 KB (21,097 words) - 22:07, 29 December 2024
- 618.html | url-status = live }}</ref> In July 2021,<!--https://www.medrxiv.org/content/10.1101/2021.07.26.21261142v1.article-info--> scientists reported...225 KB (21,654 words) - 04:28, 5 January 2025
- Virulence of Novel SARS-CoV-2 Variants in Ontario, Canada|url=https://www.medrxiv.org/content/10.1101/2021.07.05.21260050v2|website=medrxiv|doi=10.1101/2021...175 KB (14,698 words) - 05:57, 27 September 2024
- 1038/s41591-021-01377-8 | s2cid = 234769053 | doi-access = free | url = https://www.medrxiv.org/content/medrxiv/early/2021/03/11/2021.03.09.21252641.full.pdf | access-date...154 KB (13,917 words) - 20:05, 2 January 2025
- of 'hard' versus 'soft' lockdown |date=2 September 2020 |url=http://medrxiv.org/lookup/doi/10.1101/2020.08.31.20185587 |language=en |doi=10.1101/2020...127 KB (13,854 words) - 11:30, 14 December 2024
- Prudon B|s2cid=219965377|doi-access=free |title-link=doi|url=https://www.medrxiv.org/content/medrxiv/early/2020/06/22/2020.06.22.20137273.full.pdf}}</ref>...128 KB (14,907 words) - 04:25, 30 December 2024
- lineage with multiple spike mutations in South Africa|url=https://www.medrxiv.org/content/10.1101/2020.12.21.20248640v1.full-text|date=22 December...72 KB (6,075 words) - 07:31, 7 January 2025
- of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil |url=https://www.medrxiv.org/content/10.1101/2021.01.21.21249906v1.full |date=26 January 2021 |publisher=medrxiv...60 KB (4,943 words) - 20:50, 10 September 2024
- = 10.1038/s41588-020-00747-1 | s2cid = 231641761 | url = https://www.medrxiv.org/content/medrxiv/early/2020/09/18/2020.07.09.20148627.full.pdf }}</ref>...59 KB (6,008 words) - 13:42, 29 November 2024
- South African Cape Coloured population |date=2024-04-01 |url=https://www.medrxiv.org/content/10.1101/2024.03.31.24305130v2 |access-date=2024-12-16 |language=en...42 KB (4,038 words) - 14:00, 5 January 2025
- |title=Chan Zuckerberg Initiative funds medRxiv |url=https://connect.medrxiv.org/news/2020/06/18/czi_funds_medrxiv |access-date=2023-05-11...34 KB (2,766 words) - 06:57, 30 December 2024
- infection elicited neutralizing immunity |website=medRxiv |url=https://www.medrxiv.org/content/10.1101/2022.04.29.22274477v1 |access-date=24 June 2022 |language=en...541 KB (49,053 words) - 21:28, 29 December 2024
- Theacrine has [[half-life]] of 30 to 33 hours.<ref>{{Cite report |url=http://medrxiv.org/lookup/doi/10.1101/2021.01.05.21249234 |title=Caffeine and Methylliberine:...6 KB (524 words) - 00:12, 17 November 2024
- integrated clinical decision support.<ref>{{Cite web|url=https://www.medrxiv.org/content/10.1101/2023.04.02.23288046v2|title=MEDRXIV From Concept to Reality:...45 KB (5,654 words) - 15:59, 27 October 2024
- in patients with B-cell chronic lymphocytic leukemia |url=https://www.medrxiv.org/content/10.1101/2021.08.11.21261898v2 |journal=medRxiv |volume= |issue=...3 KB (278 words) - 10:09, 5 August 2024
- March 2021 |volume=24 |doi=10.1016/j.jth.2021.101290 |url=https://www.medrxiv.org/content/10.1101/2021.03.14.21253340v3.full |access-date=4 December 2023|doi-access=free...38 KB (3,988 words) - 06:20, 14 October 2024
- antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results. medRxiv.org. October 15, 2020. doi: 10.1101/2020.10.15.20209817 * The primary hypothesized